Defense reaction elicited by injection of GABA antagonists and synthesis inhibitors into the posterior hypothalamus in rats

A. Shekhar, J. A. Dimicco

Research output: Contribution to journalArticle

133 Citations (Scopus)

Abstract

Blockade of γ-aminobutyric acid (GABA) in the posterior hypothalamic nucleus elicits cardiorespiratory stimulation in anesthetized rats. The present study was conducted to test the hypothesis that blockade of GABA in this cardiostimulatory area of the posterior hypothalamus in conscious animals would elicit a defense reaction characterised by a "fight or flight" response. Blockade of GABA was achieved by injecting bicuculline methiodide (BMI 1-25 ng) and picrotoxin (4-100 ng), two post-synaptic GABA antagonists and isoniazid (INH 35 and 70 μg), an inhibitor of the synthesis of GABA, bilaterally into the posterior hypothalamus through chronically implanted microinjection cannulae. All three drugs produced dose-dependent increases in locomotor activity, suggesting an "escape" reaction which was quantified as number of crossings and rearings. The effects of bicuculline and picrotoxin appeared immediately after the injection while those of isoniazid appeared much more slowly, attaining peak effects 24 ± 1 min after injection. Injection of either strychnine (38 ng) into the posterior hypothalamus or bicuculline into the lateral hypothalamic area (LHA) or the dorso-medial/ventro-medial hypothalamus (DMH/VMH) did not elicit a significant increase in locomotor behavior. These results suggest that both the physiological and locomotor components of the hypothalamic defense reaction may be under tonic GABAergic inhibition in the region of the posterior hypothalamus.

Original languageEnglish (US)
Pages (from-to)407-417
Number of pages11
JournalNeuropharmacology
Volume26
Issue number5
DOIs
StatePublished - May 1987

Fingerprint

Posterior Hypothalamus
GABA Antagonists
gamma-Aminobutyric Acid
Picrotoxin
Injections
Bicuculline
Isoniazid
Escape Reaction
Dimenhydrinate
Lateral Hypothalamic Area
Middle Hypothalamus
Aminobutyrates
Strychnine
Microinjections
Locomotion
Pharmaceutical Preparations

Keywords

  • aversive drive
  • bicuculline
  • crossings
  • defense reaction
  • GABA
  • hypothalamus
  • isoniazid
  • picrotoxin
  • rearings

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Drug Discovery
  • Pharmacology

Cite this

Defense reaction elicited by injection of GABA antagonists and synthesis inhibitors into the posterior hypothalamus in rats. / Shekhar, A.; Dimicco, J. A.

In: Neuropharmacology, Vol. 26, No. 5, 05.1987, p. 407-417.

Research output: Contribution to journalArticle

@article{fbb07f9af0354f6e83b9926c83bd9d58,
title = "Defense reaction elicited by injection of GABA antagonists and synthesis inhibitors into the posterior hypothalamus in rats",
abstract = "Blockade of γ-aminobutyric acid (GABA) in the posterior hypothalamic nucleus elicits cardiorespiratory stimulation in anesthetized rats. The present study was conducted to test the hypothesis that blockade of GABA in this cardiostimulatory area of the posterior hypothalamus in conscious animals would elicit a defense reaction characterised by a {"}fight or flight{"} response. Blockade of GABA was achieved by injecting bicuculline methiodide (BMI 1-25 ng) and picrotoxin (4-100 ng), two post-synaptic GABA antagonists and isoniazid (INH 35 and 70 μg), an inhibitor of the synthesis of GABA, bilaterally into the posterior hypothalamus through chronically implanted microinjection cannulae. All three drugs produced dose-dependent increases in locomotor activity, suggesting an {"}escape{"} reaction which was quantified as number of crossings and rearings. The effects of bicuculline and picrotoxin appeared immediately after the injection while those of isoniazid appeared much more slowly, attaining peak effects 24 ± 1 min after injection. Injection of either strychnine (38 ng) into the posterior hypothalamus or bicuculline into the lateral hypothalamic area (LHA) or the dorso-medial/ventro-medial hypothalamus (DMH/VMH) did not elicit a significant increase in locomotor behavior. These results suggest that both the physiological and locomotor components of the hypothalamic defense reaction may be under tonic GABAergic inhibition in the region of the posterior hypothalamus.",
keywords = "aversive drive, bicuculline, crossings, defense reaction, GABA, hypothalamus, isoniazid, picrotoxin, rearings",
author = "A. Shekhar and Dimicco, {J. A.}",
year = "1987",
month = "5",
doi = "10.1016/0028-3908(87)90020-7",
language = "English (US)",
volume = "26",
pages = "407--417",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - Defense reaction elicited by injection of GABA antagonists and synthesis inhibitors into the posterior hypothalamus in rats

AU - Shekhar, A.

AU - Dimicco, J. A.

PY - 1987/5

Y1 - 1987/5

N2 - Blockade of γ-aminobutyric acid (GABA) in the posterior hypothalamic nucleus elicits cardiorespiratory stimulation in anesthetized rats. The present study was conducted to test the hypothesis that blockade of GABA in this cardiostimulatory area of the posterior hypothalamus in conscious animals would elicit a defense reaction characterised by a "fight or flight" response. Blockade of GABA was achieved by injecting bicuculline methiodide (BMI 1-25 ng) and picrotoxin (4-100 ng), two post-synaptic GABA antagonists and isoniazid (INH 35 and 70 μg), an inhibitor of the synthesis of GABA, bilaterally into the posterior hypothalamus through chronically implanted microinjection cannulae. All three drugs produced dose-dependent increases in locomotor activity, suggesting an "escape" reaction which was quantified as number of crossings and rearings. The effects of bicuculline and picrotoxin appeared immediately after the injection while those of isoniazid appeared much more slowly, attaining peak effects 24 ± 1 min after injection. Injection of either strychnine (38 ng) into the posterior hypothalamus or bicuculline into the lateral hypothalamic area (LHA) or the dorso-medial/ventro-medial hypothalamus (DMH/VMH) did not elicit a significant increase in locomotor behavior. These results suggest that both the physiological and locomotor components of the hypothalamic defense reaction may be under tonic GABAergic inhibition in the region of the posterior hypothalamus.

AB - Blockade of γ-aminobutyric acid (GABA) in the posterior hypothalamic nucleus elicits cardiorespiratory stimulation in anesthetized rats. The present study was conducted to test the hypothesis that blockade of GABA in this cardiostimulatory area of the posterior hypothalamus in conscious animals would elicit a defense reaction characterised by a "fight or flight" response. Blockade of GABA was achieved by injecting bicuculline methiodide (BMI 1-25 ng) and picrotoxin (4-100 ng), two post-synaptic GABA antagonists and isoniazid (INH 35 and 70 μg), an inhibitor of the synthesis of GABA, bilaterally into the posterior hypothalamus through chronically implanted microinjection cannulae. All three drugs produced dose-dependent increases in locomotor activity, suggesting an "escape" reaction which was quantified as number of crossings and rearings. The effects of bicuculline and picrotoxin appeared immediately after the injection while those of isoniazid appeared much more slowly, attaining peak effects 24 ± 1 min after injection. Injection of either strychnine (38 ng) into the posterior hypothalamus or bicuculline into the lateral hypothalamic area (LHA) or the dorso-medial/ventro-medial hypothalamus (DMH/VMH) did not elicit a significant increase in locomotor behavior. These results suggest that both the physiological and locomotor components of the hypothalamic defense reaction may be under tonic GABAergic inhibition in the region of the posterior hypothalamus.

KW - aversive drive

KW - bicuculline

KW - crossings

KW - defense reaction

KW - GABA

KW - hypothalamus

KW - isoniazid

KW - picrotoxin

KW - rearings

UR - http://www.scopus.com/inward/record.url?scp=0023259612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023259612&partnerID=8YFLogxK

U2 - 10.1016/0028-3908(87)90020-7

DO - 10.1016/0028-3908(87)90020-7

M3 - Article

C2 - 3037412

AN - SCOPUS:0023259612

VL - 26

SP - 407

EP - 417

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 5

ER -